HitGen to Participate in BIO International Convention 2026 Release Time：2026-06-08

BIO International Convention 2026, one of the world’s largest and most influential biotechnology events, will take place from June 22 to 25, 2026 at the San Diego Convention Center, USA. Bringing together over 20,000 global industry leaders, researchers and investors, the premier conference focuses on new drug R&D, technological innovation, industrial collaboration and technology translation, fostering global partnerships across the biopharmaceutical sector.

As a long-standing participant of the BIO Convention, HitGen will attend the 2026 event with its core leadership team led by Dr. Jin Li, Chairman & CEO of HitGen. The company will showcase its innovative technological strengths at #Booth 3943 as a key participant of the China Pavilion.

With years of dedication to global biopharmaceutical innovation, HitGen has consistently leveraged the BIO platform to exhibit proprietary technologies, connect with global industrial resources and advance international industry-university-research cooperation. During the convention, the HitGen team will engage in in-depth face-to-face discussions with global pharmaceutical professionals, academic experts and investment partners.

We aim to explore industry trends, address key challenges in drug discovery, and facilitate high-end resource docking and strategic global collaborations to drive innovative and high-quality development of the biopharmaceutical industry. HitGen looks forward to meeting global partners in San Diego to jointly embrace new opportunities for industrial innovation and cooperation.